Change search
ReferencesLink to record
Permanent link

Direct link
Credibility analysis of putative disease-causing genes using bioinformatics
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience, Clinical Neuroscience.
2013 (English)In: PLoS ONE, ISSN 1932-6203, Vol. 8, no 6, e64899- p.Article in journal (Refereed) Published
Abstract [en]

Background: Genetic studies are challenging in many complex diseases, particularly those with limited diagnostic certainty, low prevalence or of old age. The result is that genes may be reported as disease-causing with varying levels of evidence, and in some cases, the data may be so limited as to be indistinguishable from chance findings. When there are large numbers of such genes, an objective method for ranking the evidence is useful. Using the neurodegenerative and complex disease amyotrophic lateral sclerosis (ALS) as a model, and the disease-specific database ALSoD, the objective is to develop a method using publicly available data to generate a credibility score for putative disease-causing genes.

Methods: Genes with at least one publication suggesting involvement in adult onset familial ALS were collated following an exhaustive literature search. SQL was used to generate a score by extracting information from the publications and combined with a pathogenicity analysis using bioinformatics tools. The resulting score allowed us to rank genes in order of credibility. To validate the method, we compared the objective ranking with a rank generated by ALS genetics experts. Spearman's Rho was used to compare rankings generated by the different methods.

Results: The automated method ranked ALS genes in the following order: SOD1, TARDBP, FUS, ANG, SPG11, NEFH, OPTN, ALS2, SETX, FIG4, VAPB, DCTN1, TAF15, VCP, DAO. This compared very well to the ranking of ALS genetics experts, with Spearman's Rho of 0.69 (P = 0.009).

Conclusion: We have presented an automated method for scoring the level of evidence for a gene being disease-causing. In developing the method we have used the model disease ALS, but it could equally be applied to any disease in which there is genotypic uncertainty.

Place, publisher, year, edition, pages
2013. Vol. 8, no 6, e64899- p.
National Category
URN: urn:nbn:se:umu:diva-79270DOI: 10.1371/journal.pone.0064899ISI: 000320579400030OAI: diva2:645302
Available from: 2013-09-04 Created: 2013-08-13 Last updated: 2013-09-04Bibliographically approved

Open Access in DiVA

fulltext(728 kB)174 downloads
File information
File name FULLTEXT01.pdfFile size 728 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Andersen, Peter M
By organisation
Clinical Neuroscience
In the same journal

Search outside of DiVA

GoogleGoogle Scholar
Total: 174 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 196 hits
ReferencesLink to record
Permanent link

Direct link